Showing posts with label Trinova-1. Show all posts
Showing posts with label Trinova-1. Show all posts
Wednesday, May 25, 2011
Health brief media: South Coast Gyn Oncology new study Trinova-1 (+ contact info)
Clinical studies
OVARIAN CANCER: South Coast Gynecologic Oncology is enrolling women with recurrent ovarian cancer for participation in a new clinical research study, called Trinova-1. The study is open to women 18 years or older who have been diagnosed with recurrent ovarian cancer, have undergone surgery to remove at least one ovary, and have been previously treated with chemotherapy. Visit www.TRINOVA-1.com or call 858-455-5524.
Wednesday, January 26, 2011
Takeda Pharma, Millennium commence (AMG386) TRINOVA-1 Phase III cancer (ovarian) trial
Takeda Pharmaceutical and the Takeda Oncology Company: Millennium, have commenced TRINOVA-1 Phase III clinical trial on anti-cancer agent AMG 386 in Japan
Subscribe to:
Posts
(
Atom
)
